diclofenac siromed [diclofenac sopharma]
sopharma ad - diklofenako natrio druska - gelis - 10 mg/g - diclofenac
diclofenac-ratiopharm uno
ratiopharm gmbh - diklofenako natrio druska - modifikuoto atpalaidavimo tabletės - 100 mg; 75 mg/2 ml; 150 mg - diclofenac
iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. Žr. 4 skyrius. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
aciclovir claris 25 mg/ml koncentratas infuziniam tirpalui
claris life sciences (uk) limited, jungtinė karalystė - acikloviras - koncentratas infuziniam tirpalui - 25 mg/ml - aciclovir
aciclovir actavis
actavis nordic a/s - acikloviras - tabletės - 400; 200 mg; 50 mg/g - aciclovir
aciclovir siromed
stada arzneimittel ag - acikloviras - kremas - 50 mg/g - aciclovir
valaciclovir actavis
teva b.v. - valacikloviras - plėvele dengtos tabletės - 1000 mg; 500 mg; 250 mg - valaciclovir
valaciclovir elvim
sia elvim - valacikloviras - plėvele dengtos tabletės - 500 mg - valaciclovir
aciclovir baxter
baxter holding b.v. - acikloviras - koncentratas infuziniam tirpalui - 25 mg/ml - aciclovir
ciclosporin sandoz
sandoz d.d. - ciklosporinas - minkštosios kapsulės - 25 mg - ciclosporin